Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts

INTRODUCTION: More than 70 million people are estimated to be infected with hepatitis C virus (HCV) globally. If left untreated, HCV infection can lead to complications such as extensive liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Evolution of treatments has resulted in highly eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Forns, Xavier, Feld, Jordan J., Dylla, Douglas E., Pol, Stanislas, Chayama, Kazuaki, Hou, Jinlin, Heo, Jeong, Lampertico, Pietro, Brown, Ashley, Bondin, Mark, Tatsch, Fernando, Burroughs, Margaret, Marcinak, John, Zhang, Zhenzhen, Emmett, Amanda, Gordon, Stuart C., Jacobson, Ira M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189955/
https://www.ncbi.nlm.nih.gov/pubmed/34021887
http://dx.doi.org/10.1007/s12325-021-01753-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189955/
https://www.ncbi.nlm.nih.gov/pubmed/34021887
http://dx.doi.org/10.1007/s12325-021-01753-3

Ejemplares similares